203 related articles for article (PubMed ID: 28331190)
21. Circulating CD56dim natural killer cells and CD56+ T cells that produce interferon-γ or interleukin-10 are expanded in asymptomatic, E antigen-negative patients with persistent hepatitis B virus infection.
Conroy MJ; Mac Nicholas R; Grealy R; Taylor M; Otegbayo JA; O'Dea S; Mulcahy F; Ryan T; Norris S; Doherty DG
J Viral Hepat; 2015 Mar; 22(3):335-45. PubMed ID: 25186004
[TBL] [Abstract][Full Text] [Related]
22. Altered functions of plasmacytoid dendritic cells and reduced cytolytic activity of natural killer cells in patients with chronic HBV infection.
Martinet J; Dufeu-Duchesne T; Bruder Costa J; Larrat S; Marlu A; Leroy V; Plumas J; Aspord C
Gastroenterology; 2012 Dec; 143(6):1586-1596.e8. PubMed ID: 22960656
[TBL] [Abstract][Full Text] [Related]
23. Immune response pattern varies with the natural history of chronic hepatitis B.
Wang WT; Zhao XQ; Li GP; Chen YZ; Wang L; Han MF; Li WN; Chen T; Chen G; Xu D; Ning Q; Zhao XP
World J Gastroenterol; 2019 Apr; 25(16):1950-1963. PubMed ID: 31086463
[TBL] [Abstract][Full Text] [Related]
24. Simultaneous or Prior Activation of Intrahepatic Type I Interferon Signaling Leads to Hepatitis B Virus Persistence in a Mouse Model.
Zou S; Du Y; Huang S; Chen M; Yang X; Li S; Chen Y; Han M; Li J; Yu Q; Littwitz-Salomon E; Huang H; Trilling M; Liu S; Pei R; Liu J; Wang B; Zheng X; Lu M; Dittmer U; Sun S; Yang D; Wu J
J Virol; 2021 Nov; 95(24):e0003421. PubMed ID: 34550772
[TBL] [Abstract][Full Text] [Related]
25. Poly I:C prevents T cell-mediated hepatitis via an NK-dependent mechanism.
Wang J; Sun R; Wei H; Dong Z; Gao B; Tian Z
J Hepatol; 2006 Mar; 44(3):446-54. PubMed ID: 16310275
[TBL] [Abstract][Full Text] [Related]
26. PD-1/PDL1 and CD28/CD80 pathways modulate natural killer T cell function to inhibit hepatitis B virus replication.
Wang XF; Lei Y; Chen M; Chen CB; Ren H; Shi TD
J Viral Hepat; 2013 Apr; 20 Suppl 1():27-39. PubMed ID: 23458522
[TBL] [Abstract][Full Text] [Related]
27. Involvement of natural killer cells in PolyI:C-induced liver injury.
Dong Z; Wei H; Sun R; Hu Z; Gao B; Tian Z
J Hepatol; 2004 Dec; 41(6):966-73. PubMed ID: 15582130
[TBL] [Abstract][Full Text] [Related]
28. Increased susceptibility to liver injury in hepatitis B virus transgenic mice involves NKG2D-ligand interaction and natural killer cells.
Chen Y; Wei H; Sun R; Dong Z; Zhang J; Tian Z
Hepatology; 2007 Sep; 46(3):706-15. PubMed ID: 17626270
[TBL] [Abstract][Full Text] [Related]
29. Bone Marrow-Derived Mesenchymal Stem Cells Attenuate Immune-Mediated Liver Injury and Compromise Virus Control During Acute Hepatitis B Virus Infection in Mice.
Qu M; Yuan X; Liu D; Ma Y; Zhu J; Cui J; Yu M; Li C; Guo D
Stem Cells Dev; 2017 Jun; 26(11):818-827. PubMed ID: 28318408
[TBL] [Abstract][Full Text] [Related]
30. Intrahepatic natural killer cell activation, but not function, is associated with HBsAg levels in patients with HBeAg-negative chronic hepatitis B.
Tjwa ET; Zoutendijk R; van Oord GW; Biesta PJ; Verheij J; Janssen HL; Woltman AM; Boonstra A
Liver Int; 2014 Mar; 34(3):396-404. PubMed ID: 23890390
[TBL] [Abstract][Full Text] [Related]
31. CD4+CD25+ Regulatory T Cells Inhibit Natural Killer Cell Hepatocytotoxicity of Hepatitis B Virus Transgenic Mice via Membrane-Bound TGF-β and OX40.
Chen Y; Sun R; Wu X; Cheng M; Wei H; Tian Z
J Innate Immun; 2016; 8(1):30-42. PubMed ID: 26067079
[TBL] [Abstract][Full Text] [Related]
32. Exosomes mediate hepatitis B virus (HBV) transmission and NK-cell dysfunction.
Yang Y; Han Q; Hou Z; Zhang C; Tian Z; Zhang J
Cell Mol Immunol; 2017 May; 14(5):465-475. PubMed ID: 27238466
[TBL] [Abstract][Full Text] [Related]
33. Dysregulated Response of Follicular Helper T Cells to Hepatitis B Surface Antigen Promotes HBV Persistence in Mice and Associates With Outcomes of Patients.
Wang X; Dong Q; Li Q; Li Y; Zhao D; Sun J; Fu J; Meng F; Lin H; Luan J; Liu B; Wang M; Wang FS; He F; Tang L
Gastroenterology; 2018 Jun; 154(8):2222-2236. PubMed ID: 29544722
[TBL] [Abstract][Full Text] [Related]
34. Kupffer Cells Support Hepatitis B Virus-Mediated CD8+ T Cell Exhaustion via Hepatitis B Core Antigen-TLR2 Interactions in Mice.
Li M; Sun R; Xu L; Yin W; Chen Y; Zheng X; Lian Z; Wei H; Tian Z
J Immunol; 2015 Oct; 195(7):3100-9. PubMed ID: 26304988
[TBL] [Abstract][Full Text] [Related]
35. Downregulation and altered function of natural killer cells in hepatitis B virus patients treated with entecavir.
Zhao PW; Jia FY; Shan YX; Ji HF; Feng JY; Niu JQ; Ayana DA; Jiang YF
Clin Exp Pharmacol Physiol; 2013 Mar; 40(3):190-6. PubMed ID: 23278368
[TBL] [Abstract][Full Text] [Related]
36. Natural killer cells ameliorate liver fibrosis by killing activated stellate cells in NKG2D-dependent and tumor necrosis factor-related apoptosis-inducing ligand-dependent manners.
Radaeva S; Sun R; Jaruga B; Nguyen VT; Tian Z; Gao B
Gastroenterology; 2006 Feb; 130(2):435-52. PubMed ID: 16472598
[TBL] [Abstract][Full Text] [Related]
37. IL-12-based vaccination therapy reverses liver-induced systemic tolerance in a mouse model of hepatitis B virus carrier.
Zeng Z; Kong X; Li F; Wei H; Sun R; Tian Z
J Immunol; 2013 Oct; 191(8):4184-93. PubMed ID: 24048897
[TBL] [Abstract][Full Text] [Related]
38. High persistence rate of hepatitis B virus in a hydrodynamic injection-based transfection model in C3H/HeN mice.
Peng XH; Ren XN; Chen LX; Shi BS; Xu CH; Fang Z; Liu X; Chen JL; Zhang XN; Hu YW; Zhou XH
World J Gastroenterol; 2015 Mar; 21(12):3527-36. PubMed ID: 25834317
[TBL] [Abstract][Full Text] [Related]
39. Vaccination with ubiquitin-hepatitis B core antigen-cytoplasmic transduction peptide enhances the hepatitis B virus-specific cytotoxic T-lymphocyte immune response and inhibits hepatitis B virus replication in transgenic mice.
Zhuo M; Song L; Tang Y; Dai S; Chen X; Yu Y; Zang G; Tang Z
Mol Med Rep; 2015 Sep; 12(3):3591-3598. PubMed ID: 26004262
[TBL] [Abstract][Full Text] [Related]
40. Plasmacytoid dendritic cells induce efficient stimulation of antiviral immunity in the context of chronic hepatitis B virus infection.
Martinet J; Leroy V; Dufeu-Duchesne T; Larrat S; Richard MJ; Zoulim F; Plumas J; Aspord C
Hepatology; 2012 Nov; 56(5):1706-18. PubMed ID: 22707082
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
